Ost-müük Indaptus Therapeutics, Inc. - INDP CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024874% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.002651% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 1.25-4.19 |
Keskmine maht (10 päeva) | 9,410.00 |
Keskmine maht (3 kuud) | 171.47K |
Turukapitalisatsioon | 14.87M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 8.40M |
Tulu | N/A |
EPS | -1.73 |
Dividendid (% kasumist) | N/A |
Beeta | 1.19 |
Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Indaptus Therapeutics, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Tulu | |||||
Kogu tegevuskulu | 14.9109 | 7.72911 | 13.829 | 47.109 | 43.328 |
Müük/Üldine/admin kulud, kokku | 8.58625 | 5.20596 | 7.089 | 8.287 | 7.926 |
Uuringud ja arendus | 6.32466 | 2.52315 | 6.74 | 26.659 | 35.402 |
Depreciation / Amortization | |||||
Intressikulu (tulu) - neto majandustegevusest | |||||
Other Operating Expenses, Total | 0 | -1.5 | |||
Tulud majandustegevusest | -14.9109 | -7.72911 | -13.829 | -47.109 | -43.328 |
Intressitulud (kulu), muud tulud, neto | 0.01772 | -0.165 | 0.163 | -0.089 | |
Netotulu enne makse | -14.3228 | -7.71139 | -14.004 | -46.961 | -43.44 |
Netotulu pärast makse | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Netotulu enne erikulusid | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Netotulu | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Arvestatav tulu, v a erikulud | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Arvestatav tulu, koos erikuludega | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Jaotamisele kuuluv netotulu | -14.3228 | -7.71139 | -14.128 | -47.599 | -43.543 |
Keskmine jaotamisele kuuluv aktsia kohta | 8.26212 | 4.0906 | 0.86525 | 0.4222 | 0.38991 |
Jaotatav EPS, v a erakorralised kulud | -1.73355 | -1.88515 | -16.3282 | -112.74 | -111.674 |
Jaotamisele kuuluv normaal-EPS | -1.73355 | -1.88515 | -16.3282 | -91.7055 | -111.674 |
Muud, neto | 0.58811 | -0.01 | -0.015 | -0.023 | |
Ootamatud kulutused (tulu) | 0 | 13.663 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 4.08702 | 3.55255 | 3.86926 | 3.40207 | 3.2185 |
Müük/Üldine/admin kulud, kokku | 2.17518 | 1.943 | 2.3631 | 2.10498 | 2.27386 |
Uuringud ja arendus | 1.91184 | 1.60955 | 1.50617 | 1.2971 | 0.94464 |
Tulud majandustegevusest | -4.08702 | -3.55255 | -3.86926 | -3.40207 | -3.2185 |
Muud, neto | 0.43125 | 0.08618 | 0.03376 | 0.03692 | |
Netotulu enne makse | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Netotulu pärast makse | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Netotulu enne erikulusid | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Netotulu | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Arvestatav tulu, v a erikulud | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Arvestatav tulu, koos erikuludega | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Jaotamisele kuuluv netotulu | -3.65578 | -3.46637 | -3.8355 | -3.36515 | -3.21632 |
Keskmine jaotamisele kuuluv aktsia kohta | 8.27269 | 8.2586 | 8.2586 | 8.2586 | 8.28409 |
Jaotatav EPS, v a erakorralised kulud | -0.44191 | -0.41973 | -0.46443 | -0.40747 | -0.38825 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.44191 | -0.41973 | -0.46443 | -0.40747 | -0.38825 |
Intressitulud (kulu), muud tulud, neto | 0.00217 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 40.3872 | 14.968 | 13.745 | 43.565 | 56.343 |
Raha ja lühiajalised investeeringud | 39.1322 | 14.671 | 10.062 | 40.579 | 55.218 |
Raha ja ekvivalendid | 39.1322 | 14.671 | 9.292 | 39.246 | 53.393 |
Lühiajalised investeeringud | 0.77 | 1.333 | 1.825 | ||
Laekumata arved, neto | 0.085 | 3.486 | 2.031 | 0.478 | |
Accounts Receivable - Trade, Net | 0.085 | 3.486 | 2.031 | 0.478 | |
Other Current Assets, Total | 0.1484 | ||||
Total Assets | 40.5766 | 20.896 | 21.28 | 61.51 | 64.549 |
Property/Plant/Equipment, Total - Net | 0.17289 | 2.211 | 3.818 | 12.233 | 8.206 |
Total Current Liabilities | 4.60414 | 5.334 | 8.342 | 7.656 | 5.747 |
Payable/Accrued | 4.50768 | 0.368 | 3.507 | 2.849 | 1.854 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 4.37 | 4.835 | 0.02 | 0.033 | |
Total Liabilities | 4.677 | 6.363 | 9.745 | 7.965 | 5.747 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.07286 | 1.029 | 1.403 | 0.309 | 0 |
Total Equity | 35.8996 | 14.533 | 11.535 | 53.545 | 58.802 |
Common Stock | 0.08259 | 0.727 | 0.727 | 0.727 | 0.727 |
Additional Paid-In Capital | 51.4879 | 217.357 | 200.231 | 194.642 | 156.356 |
Retained Earnings (Accumulated Deficit) | -15.6709 | -203.551 | -189.423 | -141.824 | -98.281 |
Other Equity, Total | |||||
Total Liabilities & Shareholders’ Equity | 40.5766 | 20.896 | 21.28 | 61.51 | 64.549 |
Total Common Shares Outstanding | 8.2586 | 1.08032 | 0.44865 | 0.41541 | 0.32595 |
Prepaid Expenses | 1.10665 | 0.212 | 0.197 | 0.955 | 0.647 |
Property/Plant/Equipment, Total - Gross | 10.61 | 11.014 | 18.575 | 13.689 | |
Accumulated Depreciation, Total | -8.399 | -7.196 | -6.342 | -5.483 | |
Other Long Term Assets, Total | 0.01648 | 3.717 | 3.717 | 5.712 | 0 |
Accrued Expenses | 0.09647 | 0.596 | 4.787 | 3.86 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 36.9197 | 40.3872 | 43.8549 | 18.792 | 12.159 |
Raha ja lühiajalised investeeringud | 36.1778 | 39.1322 | 41.8572 | 16.991 | 10.135 |
Raha ja ekvivalendid | 33.2163 | 39.1322 | 41.8572 | 16.991 | 10.135 |
Prepaid Expenses | 0.74195 | 1.10665 | 1.39767 | 0.801 | 1.024 |
Other Current Assets, Total | 0 | 0.1484 | 0.6 | 1 | 1 |
Total Assets | 37.0866 | 40.5766 | 43.8592 | 20.092 | 17.43 |
Property/Plant/Equipment, Total - Net | 0.15037 | 0.17289 | 0.00434 | 0 | 1.554 |
Other Long Term Assets, Total | 0.01648 | 0.01648 | 1.3 | 3.717 | |
Total Current Liabilities | 3.67966 | 4.60414 | 5.78018 | 5.44 | 5.203 |
Payable/Accrued | 0.40032 | 4.50768 | 5.78018 | 0.397 | 0.183 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 5.043 | 5.02 | |||
Total Liabilities | 3.73017 | 4.677 | 5.78018 | 6.156 | 6.086 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.05052 | 0.07286 | 0.716 | 0.883 | |
Total Equity | 33.3564 | 35.8996 | 38.079 | 13.936 | 11.344 |
Common Stock | 0.08259 | 0.08259 | 0.08133 | 0.727 | 0.727 |
Additional Paid-In Capital | 52.3191 | 51.4879 | 50.4523 | 228.421 | 218.397 |
Retained Earnings (Accumulated Deficit) | -19.036 | -15.6709 | -12.4546 | -215.212 | -207.78 |
Total Liabilities & Shareholders’ Equity | 37.0866 | 40.5766 | 43.8592 | 20.092 | 17.43 |
Total Common Shares Outstanding | 8.2586 | 8.2586 | 8.13324 | 1.85874 | 1.12565 |
Accrued Expenses | 0.44466 | 0.09647 | |||
Lühiajalised investeeringud | 2.96146 | ||||
Accounts Payable | 2.83468 | ||||
Other Equity, Total | -0.00922 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -7.71139 | -14.128 | -47.599 | -43.543 | -28.909 |
Raha majandustegevusest | -11.2905 | -11.511 | -29.045 | -39.076 | -22.132 |
Raha majandustegevusest | 0.0014 | 1.203 | 0.854 | 0.859 | 0.829 |
Mittelikviidsed varad | 1.49378 | 1.001 | 17.192 | 4.25 | 0.858 |
Muutused tööjõus | -5.07433 | 0.413 | 0.508 | -0.642 | 5.09 |
Tulu investeeringutelt | 0.44775 | 0.75 | -3.21 | -9.301 | -4.747 |
Kapitalikulutused | -0.00385 | -0.022 | -0.921 | -4.667 | -5.001 |
Muud rahavood investeeringutelt, kokku | 0.4516 | 0.772 | -2.289 | -4.634 | 0.254 |
Rahavood investeeringutelt | 48.3375 | 15.978 | 2.368 | 35.059 | 63.707 |
Aktsiate emiteerimine (tagasiost), neto | 27.6565 | 15.907 | 2.368 | 35.059 | 63.707 |
Muutused valuutakursside kõikumisest | 0.162 | -0.067 | -0.829 | 0.127 | |
Rahaline kogumuutus | 37.4947 | 5.379 | -29.954 | -14.147 | 36.955 |
Cash Taxes Paid | 0.0008 | 0.009 | 0.075 | 0.096 | 0 |
Rahavoogudesse investeerimine | 20.681 | 0.071 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.36515 | -7.71139 | -4.49506 | -11.661 | -0.61242 |
Cash From Operating Activities | -3.11773 | -11.2905 | -7.75082 | -7.397 | -0.82558 |
Cash From Operating Activities | 0.00053 | 0.0014 | 0.00087 | 1.178 | 0.00021 |
Non-Cash Items | 0.80703 | 1.49378 | 0.83646 | 3.493 | 0.02045 |
Cash Taxes Paid | 0 | 0.0008 | 0.0008 | 0.01 | 0.0008 |
Changes in Working Capital | -0.56014 | -5.07433 | -4.09308 | -0.407 | -0.23382 |
Cash From Investing Activities | -2.79813 | 0.44775 | -0.00385 | 0 | 0 |
Other Investing Cash Flow Items, Total | -2.79813 | 0.4516 | 0 | 0 | |
Cash From Financing Activities | 0 | 48.3375 | 47.9744 | 10.856 | 3.675 |
Financing Cash Flow Items | 0 | 20.681 | 20.681 | 3.675 | |
Net Change in Cash | -5.91585 | 37.4947 | 40.2197 | 3.32 | 2.84942 |
Capital Expenditures | -0.00385 | -0.00385 | 0 | ||
Issuance (Retirement) of Stock, Net | 27.6565 | 27.2934 | 10.856 | ||
Foreign Exchange Effects | -0.139 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Newman (Michael James) | Individual Investor | 16.2879 | 1368356 | 0 | 2022-08-03 | LOW |
Anderson (Glen R) | Individual Investor | 12.9394 | 1087048 | 348956 | 2022-07-07 | MED |
Lee (Hoonmo) | Individual Investor | 8.2671 | 694522 | 0 | 2021-09-29 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.98 | 250348 | 101 | 2022-12-31 | LOW |
The Investment House LLC | Investment Advisor | 1.1383 | 95629 | 0 | 2022-12-31 | LOW |
Meckler (Jeffrey A) | Individual Investor | 0.8972 | 75374 | 10000 | 2022-11-21 | LOW |
Strategy Asset Managers, L.L.C. | Investment Advisor | 0.6587 | 55336 | 0 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6014 | 50521 | -101 | 2022-12-31 | LOW |
Stratos Wealth Partners, Ltd. | Investment Advisor | 0.3194 | 26832 | 0 | 2022-12-31 | LOW |
Vivaldi Capital Management, LLC | Investment Advisor/Hedge Fund | 0.2857 | 24000 | 0 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2318 | 19473 | 0 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.2274 | 19100 | -600 | 2022-12-31 | HIGH |
Susquehanna International Group, LLP | Investment Advisor | 0.1725 | 14495 | 14495 | 2022-12-31 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1141 | 9587 | 0 | 2022-12-31 | LOW |
Tower Research Capital LLC | Hedge Fund | 0.0803 | 6742 | 6418 | 2022-12-31 | HIGH |
Northern Trust Global Investments | Investment Advisor | 0.0394 | 3311 | 0 | 2022-12-31 | LOW |
Litchev (Boyan Vesselinov) | Individual Investor | 0.0137 | 1150 | 500 | 2022-12-01 | HIGH |
Maddaluna (Anthony J) | Individual Investor | 0.008 | 670 | 0 | 2022-08-03 | LOW |
Bangor Savings Bank | Bank and Trust | 0.0048 | 400 | 0 | 2022-12-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 0.0043 | 365 | 0 | 2022-12-31 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Indaptus Therapeutics, Inc. Company profile
Ettevõttest Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc, endine Intec Parent, Inc, pakub immunoteraapiat haiguste ravimiseks. Ettevõte tegeleb prekliiniliste ravikandidaatide väljatöötamisega, et tekitada kasvajavastaseid ja viirusevastaseid vastuseid ning ravida haigusi. Ettevõte töötab oma lähenemisviisi välja konkreetsete kasvaja või viiruse antigeenide vastu. Ettevõtte juhtiv kandidaat Decoy20 on prekliinilises arenduses. Ettevõtte platvorm põhineb hüpoteesil, et kasvajavastane immunoteraapia peab aktiveerima nii kaasasündinud kui ka adaptiivse rakulise immuunsuse nii kasvajates kui ka immuunsüsteemi organites. Tema lähenemisviis kasutab mitmele sihtmärgile suunatud bakteriaalsete patogeenidega seotud molekulaarmustrite (PAMP) paketti nõrgestatud ja tapetud, intaktsete, kuid mittepatogeensete bakterite kujul, mida manustatakse intravenoosselt. Tema intravenoosselt manustatavad ravikandidaadid on suunatud maksale, põrnale ja kasvajate lekkivale veresoonkonnale, tekitades immuunsüsteemi aktiveerimise immuunsüsteemi organis, samuti primaarse ja metastaatilise vähi ning B-hepatiidi viiruse (HBV) infektsiooni ühises kohas.
Industry: | Biotechnology & Medical Research (NEC) |
3 Columbus Circle
15Th Floor
10019
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com